Bibliography
Found 11 results
Filters: Keyword is Disease Progression [Clear All Filters]
The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 ;23(2):290-303.
. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2006 ;21(1):83-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16169705
. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS (London, England) [Internet]. 2006 ;20(6):879-87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16549972
Cortical demyelination in PML and MS: Similarities and differences. Neurology [Internet]. 2008 ;70:336-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17914063
. Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2007 ;12:1488-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17127396
. Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis?. Atherosclerosis. 2014 ;235(2):371-9.
. The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis. Int J Mol Sci. 2018 ;19(5).
. Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)–2',3'-dideoxycytidine (ddC): relevance to HIV-dementia. Experimental Neurology [Internet]. 2007 ;204(1):29-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17069802
. Risk of developing cerebral β-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 ;33(14):2157-2166.
.